Dennis McCarty
YOU?
Author Swipe
View article: How Did Medicaid's 1115 Substance Use Disorder Waivers Increase Medication Treatment for Opioid Use Disorder? Evidence From Eight Waiver States
How Did Medicaid's 1115 Substance Use Disorder Waivers Increase Medication Treatment for Opioid Use Disorder? Evidence From Eight Waiver States Open
Policy Points States can use substance use disorder waivers to improve their program, but findings regarding the effects of these waivers on opioid use disorder medication treatment have shown mixed results. This study used a mixed‐methods…
View article: Treating job-related stress with psychedelic group therapy: a case series on group ketamine-assisted psychotherapy for healthcare workers and first responders
Treating job-related stress with psychedelic group therapy: a case series on group ketamine-assisted psychotherapy for healthcare workers and first responders Open
Background: Job-related stress and its extreme form, burnout, continue to affect almost half of all frontline healthcare workers and first responders. Current treatments are inadequate. Objectives: To evaluate a model of ketamine-assisted …
View article: The Impacts of 1115 Medicaid Substance Use Disorder Waivers on Medicaid‐Paid Use of Residential Treatment and Other Types of Services in 20 States
The Impacts of 1115 Medicaid Substance Use Disorder Waivers on Medicaid‐Paid Use of Residential Treatment and Other Types of Services in 20 States Open
Objective To assess the association between the implementation of 1115 Medicaid substance use disorder (SUD) waivers and changes in Medicaid‐paid use of residential treatment and other types of services. Study Setting and Design We compare…
View article: Recognizing Our Biases, Understanding the Evidence, and Responding Equitably
Recognizing Our Biases, Understanding the Evidence, and Responding Equitably Open
BACKGROUND: Implicit bias permeates beliefs and actions both personally and professionally and results in negative health outcomes for people of color-even in the neonatal intensive care unit (NICU). NICU clinicians may naïvely and incorre…
View article: Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts
Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts Open
Emerging legal frameworks in Oregon and Colorado license facilitators to support adults receiving psychedelic services. The current legal frameworks are silent regarding facilitators’ personal experience with psychedelics. An eDelphi proce…
View article: Engaging the Great Circle: a qualitative study of the Confederated Tribes of Grand Ronde’s mobile medication unit
Engaging the Great Circle: a qualitative study of the Confederated Tribes of Grand Ronde’s mobile medication unit Open
The Great Circle MMU enhanced access to opioid agonist therapy for people with OUD (i.e. American Indians/Alaska Natives, and non-natives) living in rural communities. The Confederated Tribes of Grand Ronde operates the first Tribally owne…
View article: Usability and feasibility of a take-home methadone web-application for opioid treatment program patients: A Small Business Innovation Research mixed methods study
Usability and feasibility of a take-home methadone web-application for opioid treatment program patients: A Small Business Innovation Research mixed methods study Open
A Stage IA study informed the development and maturation of a Stage IB feasibility pilot study. Overall, the take-home app's usability, acceptability, appropriateness, and feasibility were rated positively. Clinical staff ratings were less…
View article: Addiction severity and re-employment in Sweden among adults with risky alcohol and drug use
Addiction severity and re-employment in Sweden among adults with risky alcohol and drug use Open
This study suggests that several ASI domains may provide information on the complex factors (i.e., mental health, health, drug use) associated with long-term unemployment for people with risky substance use.
View article: State- and County-Level Geographic Variation in Opioid Use Disorder, Medication Treatment, and Opioid-Related Overdose Among Medicaid Enrollees
State- and County-Level Geographic Variation in Opioid Use Disorder, Medication Treatment, and Opioid-Related Overdose Among Medicaid Enrollees Open
Importance The opioid crisis disproportionately affects Medicaid enrollees, yet little systematic evidence exists regarding how prevalence of and health care utilization for opioid use disorder (OUD) vary across geographical areas. Objecti…
View article: Recurrent risk of hospitalization among older people with problematic alcohol use: a multiple failure‐time analysis with a discontinuous risk model
Recurrent risk of hospitalization among older people with problematic alcohol use: a multiple failure‐time analysis with a discontinuous risk model Open
Background and aims Older people with problematic alcohol use vary in psychosocial functioning, age of onset for problem drinking and use of other drugs. The study measured the differential risks of all‐cause, alcohol‐, polydrug‐ and psych…
View article: Hospital Admission Rate, Cumulative Hospitalized Days, and Time to Admission Among Older Persons With Substance Use and Psychiatric Conditions
Hospital Admission Rate, Cumulative Hospitalized Days, and Time to Admission Among Older Persons With Substance Use and Psychiatric Conditions Open
Background Substance use among older persons occurs with medical and psychiatric comorbidities. This study examined the associations of substance use disorder (SUD), psychiatric, and dual diagnoses with 12-month cumulative hospitalized day…
View article: Development and implementation of a prescription opioid registry across diverse health systems
Development and implementation of a prescription opioid registry across diverse health systems Open
Objective Develop and implement a prescription opioid registry in 10 diverse health systems across the US and describe trends in prescribed opioids between 2012 and 2018. Materials and Methods Using electronic health record and claims data…
View article: HIV clinic‐based extended‐release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non‐blinded, randomized non‐inferiority trial
HIV clinic‐based extended‐release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non‐blinded, randomized non‐inferiority trial Open
Background and aim Opioid agonist medications for treatment of opioid use disorder (OUD) can improve human immunodeficiency virus (HIV) outcomes and reduce opioid use. We tested whether outpatient antagonist treatment with naltrexone could…
View article: Differences in the Delivery of Medications for Opioid use Disorder during Hospitalization by Racial Categories: A Retrospective Cohort Analysis;
Differences in the Delivery of Medications for Opioid use Disorder during Hospitalization by Racial Categories: A Retrospective Cohort Analysis; Open
Background: As the drug-related overdose crisis and COVID-19 pandemic continue, communities need increased access to medications for opioid use disorder (MOUD) (i.e., buprenorphine and methadone). Disparities in the type of MOUD prescribed…
View article: Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis
Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis Open
Background In the United States, methadone for opioid use disorder (OUD) is highly regulated. Federal agencies announced guidelines in March 2020 allowing for relaxation of take-home methadone dispensing at opioid treatment programs (OTPs)…
View article: Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis
Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis Open
Background The CHOICES study randomized participants with HIV and opioid use disorder (OUD) to HIV clinic-based extended-release naltrexone (XR-NTX), which requires complete cessation of opioid use, versus treatment-as-usual (i.e., bupreno…
View article: Opioid Treatment Programs, Telemedicine and COVID-19: A Scoping Review
Opioid Treatment Programs, Telemedicine and COVID-19: A Scoping Review Open
Background: Methadone and buprenorphine are effective medications for opioid use disorder (MOUD) that are highly regulated in the United States. The on-going opioid crisis, and more recently COVID-19, has prompted reconsideration of these …
View article: Office-Based Methadone Treatment for Opioid Use Disorder and Pharmacy Dispensing: A Scoping Review
Office-Based Methadone Treatment for Opioid Use Disorder and Pharmacy Dispensing: A Scoping Review Open
Limited research suggests that office-based methadone treatment and pharmacy dispensing could enhance access to methadone treatment for patients with opioid use disorder without adversely affecting patient outcomes and, potentially, inform…
View article: Effectiveness of and Access to Medications for Opioid Use Disorder for Adolescents and Young Adults: A Scoping Review
Effectiveness of and Access to Medications for Opioid Use Disorder for Adolescents and Young Adults: A Scoping Review Open
Objective A scoping review assessed access to medications for opioid use disorder (MOUD) and treatment outcomes among adolescents (12 – 17 years) and young adults (18 – 25 years). Methods Studies addressing adolescent and young adult opioi…
View article: Recommendations to Inform Substance Use Disorder Data Sharing Research: Scoping Review and Thematic Analysis
Recommendations to Inform Substance Use Disorder Data Sharing Research: Scoping Review and Thematic Analysis Open
Objectives Title 42 Code of Federal Regulations Part 2 (42 CFR Part 2 or Part 2) was enacted in 1975 to protect patients receiving treatment for substance use disorders. A scoping review on Part 2 characterized published work. Methods Seve…
View article: Article Commentary: Research Priorities for Expanding access to Methadone Treatment for Opioid use Disorder in the United States: A National Institute on Drug Abuse Clinical Trials Network Task Force Report
Article Commentary: Research Priorities for Expanding access to Methadone Treatment for Opioid use Disorder in the United States: A National Institute on Drug Abuse Clinical Trials Network Task Force Report Open
In the US, methadone treatment can only be provided to patients with opioid use disorder (OUD) through federal and state-regulated opioid treatment programs (OTPs). There is a shortage of OTPs, and racial and geographic inequities exist in…